SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-106744
Filing Date
2020-09-21
Accepted
2020-09-21 07:10:58
Documents
12
Period of Report
2020-09-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2031376-1_8k.htm   iXBRL 8-K 25630
2 EXHIBIT 99.1 tm2031376d1_ex99-1.htm EX-99.1 22172
3 GRAPHIC tm2031376d1_ex99-1img001.jpg GRAPHIC 8793
  Complete submission text file 0001104659-20-106744.txt   242452

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA axsm-20200521.xsd EX-101.SCH 3180
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE axsm-20200521_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axsm-20200521_pre.xml EX-101.PRE 22706
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2031376-1_8k_htm.xml XML 3723
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 201185175
SIC: 2834 Pharmaceutical Preparations